Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Harvard Business School
Colorcon
Express Scripts
Boehringer Ingelheim
Cipla
AstraZeneca
Medtronic
Accenture
Covington

Generated: February 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020872

« Back to Dashboard

NDA 020872 describes CHILDREN'S ALLEGRA HIVES, which is a drug marketed by Sanofi Aventis Us and is included in three NDAs. It is available from seven suppliers. There are two patents protecting this drug. Additional details are available on the CHILDREN'S ALLEGRA HIVES profile page.

The generic ingredient in CHILDREN'S ALLEGRA HIVES is fexofenadine hydrochloride. There are twenty-three drug master file entries for this compound. One hundred and two suppliers are listed for this compound. Additional details are available on the fexofenadine hydrochloride profile page.
Summary for 020872
Tradename:CHILDREN'S ALLEGRA HIVES
Applicant:Sanofi Aventis Us
Ingredient:fexofenadine hydrochloride
Patents:0
Therapeutic Class:Respiratory Tract Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 020872
Suppliers and Packaging for NDA: 020872
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ALLEGRA ALLERGY fexofenadine hydrochloride TABLET;ORAL 020872 NDA NCS HealthCare of KY, Inc dba Vangard Labs 0615-5619 N 0615-5619-39
ALLEGRA ALLERGY fexofenadine hydrochloride TABLET;ORAL 020872 NDA NCS HealthCare of KY, Inc dba Vangard Labs 0615-5620 N 0615-5620-39

Profile for product number 005

Active Rx/OTC/Discontinued:OTCDosage:TABLET;ORALStrength30MG
Approval Date:Jan 24, 2011TE:RLD:Yes

Profile for product number 006

Active Rx/OTC/Discontinued:OTCDosage:TABLET;ORALStrength30MG
Approval Date:Jan 24, 2011TE:RLD:Yes

Profile for product number 007

Active Rx/OTC/Discontinued:OTCDosage:TABLET;ORALStrength60MG
Approval Date:Jan 24, 2011TE:RLD:Yes

Expired US Patents for NDA 020872

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Queensland Health
Express Scripts
Colorcon
Deloitte
Cerilliant
QuintilesIMS
Merck
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot